0001387131-22-010043.txt : 20220927
0001387131-22-010043.hdr.sgml : 20220927
20220927174640
ACCESSION NUMBER: 0001387131-22-010043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220923
FILED AS OF DATE: 20220927
DATE AS OF CHANGE: 20220927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danahy Kevin Patrick
CENTRAL INDEX KEY: 0001913245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 221272306
MAIL ADDRESS:
STREET 1: 50 TEABERRY LANE
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pulse Biosciences, Inc.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
danahy-form4_092722.xml
FORM 4
X0306
4
2022-09-23
0
0001625101
Pulse Biosciences, Inc.
PLSE
0001913245
Danahy Kevin Patrick
C/O PULSE BIOSCIENCES, INC.
3957 POINT EDEN WAY
HAYWARD
CA
94545
0
1
0
0
Chief Executive Officer
Stock Option (right to buy)
1.53
2022-09-23
4
A
0
450000
A
2032-09-23
Common Stock
450000
450000
D
The option was granted on September 23, 2022 under the Issuer's 2017 Equity Incentive Plan and pursuant to an amendment to the Reporting Person's employment agreement. The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.
Not applicable.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2022-09-27